Biodesix Inc. (BDSX) Tops Q2 EPS by 4c

Biodesix Inc. (NASDAQ: BDSX) reported Q2 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $11.9 million versus the consensus estimate of $11.67 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Jefferies on Yeti Holdings Inc. (YETI): 'Reiterate Buy on Today's Weakness'
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation